Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 30.20
-0.32 (-1.05%)
At close: Feb 13, 2026
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 5.98 billion as of February 13, 2026. Its market cap has increased by 76.92% in one year.
Market Cap
5.98B
Enterprise Value
6.77B
Revenue
1.52B
Ranking
n/a
PE Ratio
48.73
Stock Price
30.20
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 5.98B, a decrease of -26.58%. That is a compound annual growth rate of -5.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.98B | -4.64% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Konruns Pharmaceutical | 6.80B |
| Shenzhen Weiguang Biological Products | 6.51B |
| PharmaResources (Shanghai) | 6.35B |
| Novogene | 6.31B |
| Xiangxue Pharmaceutical | 6.21B |
| Lifecome Biochemistry | 5.85B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.80B |
| Jiangsu Bioperfectus Technologies | 5.75B |